Showing results (221-230 of 607) with videos related to

Sort By:
Pageof 61
Journal of Pharmaceutical and Biomedical Analysis|January 3, 2021
A robust multiplexed assay to quantify C1-inhibitor, C1q, and C4 proteins for in vitro diagnosis of hereditary angioedema from dried blood spotYongquan Lai, Guodong Zhang, Neil Inhaber, et al.
Scientific Reports|June 3, 2017
Isolated Congenital Anosmia and CNGA2 MutationM Reza Sailani, Inlora Jingga, Seyed Hashem MirMazlomi, et al.
The Journal of Allergy and Clinical Immunology. Global|December 9, 2024
Subtype prevalence and treatment implication in adolescents and adults with mild-to-moderate asthma: Systematic review and meta-analysisChamard Wongsa, Pakpoom Wongyikul, Piyaporn Chokevittaya, et al.
Dermatology and Therapy|February 28, 2025
Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous UrticariaKarsten Weller, Tonya Winders, Jessica McCarthy, et al.
Pediatric Neurology|November 27, 2022
A Cross-Sectional Study of the Neuropsychiatric Phenotype of CACNA1C-Related DisorderRebecca J Levy, Katherine W Timothy, Jack F G Underwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 13, 2018
Phrank measures phenotype sets similarity to greatly improve Mendelian diagnostic disease prioritizationKarthik A Jagadeesh, Johannes Birgmeier, Harendra Guturu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2023
Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsWasuchon Chaichan, Chidchanok Ruengorn, Kednapa Thavorn, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 12, 2025
Validation of the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL)Melba Muñoz, Pascale Salameh, Sabine Altrichter, et al.
The European Respiratory Journal|November 5, 2016
A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthmaEckard Hamelmann, Jonathan A Bernstein, Mark Vandewalker, et al.
JAMA Dermatology|November 15, 2018
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" EvidenceMichael D Tharp, Jonathan A Bernstein, Abhishek Kavati, et al.
Pageof 61